We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. OK, I agree | Cookies Policy

XILAPLUS®

1

The role of mucoprotectants in the management of gastrointestinal disorders.

Eutamene, Beaufrand Harkat C, Theodorou V.

“The new mucoprotectants, such as gelatin tannate and xyloglucan, have the ability to protect the intestinal mucosa and to exert anti-diarrheal effects. In the future the ability of these substances to enhance the intestinal barrier may extend their use in the management of a variety of gastro-intestinal diseases associated with ‘leaky gut’.

Read more

Undissociated gelatine tannate and xyloglucan prevent gut leakiness and mucosal inflammation induced by LPS: insights in the mechanism of action.

H. Eutamene. P1449.

UEG journal. October 2016. Vol 4. Suppl. 1 Pag A651Introduction:Gelatine tannate (GT) and xylogucan (XG) are commercially available in several countries for the oral treatment of diarrhea in children and adults. However, the mechanism of action remains poorly understood.Aims & Methods...

Read more

Let's meet in..

2019, Nov 05

CPhI 2019

Read more

2019, Nov 25

euroPLX 71

Read more

2019, Nov 28

PharmaVenue November 2019

Read more